It’s a jungle out there. Deriving the right royalty rate for new pharmaceuticals and biotechnologies is a real tangle. This is a critical business function, and it has never been more important ...
“Free market” license agreements may entail a range of supra-FRAND royalty rates that reflect varied hold-up values. It is crucial for the negotiating parties and courts to recognize the possibility ...